MMDA (drug)

From WikiMD's WELLNESSPEDIA

MMDA-structure

MMDA (3-methoxy-4,5-methylenedioxyamphetamine) is a psychoactive drug that belongs to the amphetamine class. It is also known as "Adam" or "Sass" in recreational settings. MMDA is structurally similar to MDMA (ecstasy) and MDA, but it has distinct effects and pharmacological properties.

History[edit]

MMDA was first synthesized by the American chemist Alexander Shulgin in the 1960s. Shulgin extensively studied the compound and documented its effects in his book PiHKAL (Phenethylamines I Have Known and Loved). MMDA gained popularity in the 1970s as a recreational drug, often used in combination with other substances like LSD or marijuana.

Pharmacology[edit]

MMDA acts primarily as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), meaning it increases the levels of these neurotransmitters in the brain. It also has mild agonist activity at serotonin receptors. The exact mechanism of action and the full range of effects of MMDA are not yet fully understood.

Effects[edit]

The effects of MMDA are similar to those of other entactogens, such as MDMA. Users typically experience feelings of euphoria, increased empathy, and enhanced sensory perception. MMDA is also known to produce mild hallucinogenic effects, including visual distortions and color enhancement. The duration of the effects can last between 4 to 8 hours, depending on the dose and individual metabolism.

Risks and Side Effects[edit]

As with any psychoactive substance, MMDA carries certain risks and potential side effects. These can include increased heart rate, elevated blood pressure, dehydration, and hyperthermia. MMDA may also cause psychological effects such as anxiety, paranoia, and panic attacks. Prolonged or excessive use of MMDA can lead to neurotoxicity and long-term cognitive impairments.

Legal Status[edit]

The legal status of MMDA varies from country to country. In most jurisdictions, MMDA is classified as a controlled substance due to its psychoactive properties. Its production, distribution, and possession are generally illegal without proper authorization. It is important to note that the laws surrounding MMDA and other similar substances are subject to change, so it is advisable to consult local regulations before engaging in any activities involving MMDA.

See Also[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=MMDA_(drug)&oldid=6099883"